Evidence map›Paper›PMID 21646301›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2011

T cell lineage commitment: identity and renunciation.

Ellen V Rothenberg

Abstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. γ-Secretase fanning the fire of innate immunity.Biochemical Society transactions · 2023
    Review
  6. Article
  7. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  8. Review
  9. Article
  10. From thymus to tissues and tumors: A review of T-cell biology.The Journal of allergy and clinical immunology · 2023
    Review
  11. MicroRNAs in T Cell-Immunotherapy.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. A regulatory network of microRNAs confers lineage commitment during early developmental trajectories of B and T lymphocytes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. TCRCell · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ellen V RothenbergDivision of Biology, California Institute of Technology, Pasadena, CA 91125, USA. evroth@its.caltech.edu

Funding

LINEAGE COMMITMENT MECHANISMS IN LYMPHOID PRECURSORSR01CA090233 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2001 to 2011
$3.9M
Bcl11b in early T cell developmentR01AI083514 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2011 to 2015
$1.8M
GATA-3 in precursor commitment to the T lineageR01CA098925 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2003 to 2007
$1.8M
Reverse engineering genetic network architecture of stem-cell/lymphocyte transitiR33HL089123 · NHLBI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2007 to 2009
$1.6M
Dynamic Epigenetic Mapping of a Stem Cell Differentiation ChoiceRC2CA148278 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V., WOLD, BARBARA J · 2009 to 2010
$1.6M
CIS-REGULATORY ANALYSIS OF PU.1 BY IN VITRO ES CELL DIFFERENTIATIONR21DK073658 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2006 to 2007
$416k
Bcl11b in early T cell developmentR56AI083514 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2010 to 2010
$405k
NCI NIH HHS CA148278NCI NIH HHS CA90233NCI NIH HHS CA98925NCI NIH HHS R01 CA090233NCI NIH HHS R01 CA098925NCI NIH HHS RC2 CA148278NHLBI NIH HHS HL089123NHLBI NIH HHS R33 HL089123NIAID NIH HHS AI083514NIAID NIH HHS R01 AI083514NIAID NIH HHS R56 AI083514NIDDK NIH HHS DK073658NIDDK NIH HHS R21 DK073658
6 · The paper itself

Abstract

Precursors undertaking T cell development shed their access to other pathways in a sequential process that begins before entry into the thymus and continues through many cell cycles afterward. This process involves three levels of regulatory change, in which the cells' intrinsic transcriptional regulatory factors, expression of signaling receptors (e.g., Notch1), and expression of distinct homing receptors separately contribute to confirmation of T cell identity. Each alternative potential has a different underlying molecular basis that is neutralized and then permanently silenced through different mechanisms in early T cell precursors. This regulatory mosaic has notable implications for the hierarchy of relationships linking T lymphocytes to other hematopoietic fates.

Indexed as

AnimalsCell LineageHumansT-LymphocytesTranscription FactorsTranscription Factors

Identifiers

PMID21646301
PMCPMC3111953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.